IGF2 and Huntington disease: Additionally, cell culture models of HD showed that IGF2 treatment enhanced the unconventional disposal of soluble polyglutamine peptide material into the extracellular space through secretion of EVs, thus reducing the accumulation of intracellular mHtt and polyglutamine peptide aggregates.